Newsletter Subject

Apple, Google, Microsoft, and Washington are betting big

From

rogueeconomics.com

Email Address

feedback@exct.rogueeconomics.com

Sent On

Thu, Dec 14, 2023 02:10 PM

Email Preheader Text

Warning: Only 48 hours left to get in on this… . So make sure you watch the video now, while yo

Warning: Only 48 hours left to get in on this… [Header] Hi, Nomi here with a short update for you… Thanks to the FDA and the U.S. government… a massive AI revolution is quietly taking over the trillion-dollar healthcare industry… Tech giants from Apple to Google are collaborating with academic institutions and some of the world’s largest pharmaceutical companies… The Food and Drug Administration has started massively escalating and fast-tracking its approvals of artificial intelligence tools for use in health care… The ultimate aim is for these devices to be used to flag cancers, heart disease, and other life-threatening illnesses. This is just the beginning. Microsoft partnered with Novartis to use AI to “transform how medicines are discovered, developed, and commercialized.” In early 2021, Google and Boehringer Ingelheim teamed up in “pharmaceutical research and development.” Why? Because AI can research and develop drugs… faster and cheaper… This opportunity is unfolding at a breakneck pace. [Get the details here.]( [Nomi Prins signature] Nomi Prins Editor, Rogue Economics P.S. To give you every opportunity to take part in this, we’re extending the original offer only until midnight tomorrow night. You may never have another chance to claim a FREE YEAR and get in [at this low price](. So make sure you watch the video now, while you still have time before we shut down access tomorrow at midnight. © 2023 Rogue Economics. All rights reserved. 455 NE 5th Ave Suite D384, Delray Beach, FL 33483. To ensure our emails continue reaching your inbox, please [add our email address]( to your address book. No longer wish to receive special offers from us? Click [here]( for options.

Marketing emails from rogueeconomics.com

View More
Sent On

06/12/2024

Sent On

04/12/2024

Sent On

08/11/2024

Sent On

02/11/2024

Sent On

01/11/2024

Sent On

29/10/2024

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2025 SimilarMail.